Related Experiment Videos
[Somatic and biological factors predicting a response to antidepressive agents]
1S.H.U., Hôpital Sainte-Anne, Paris.
L'Encephale
|December 1, 1991
Summary
Predicting antidepressant response remains challenging. While some factors like retardation show promise, no single reliable biological marker is currently available for routine clinical use.
Area of Science:
- Psychiatry
- Neuroscience
- Pharmacology
Context:
- Antidepressant trials require controlling for non-specific factors like illness course and placebo effects.
- Identifying reliable predictors of treatment response is crucial for personalized medicine in psychiatry.
Purpose:
- To evaluate the predictive value of somatic and biological factors in antidepressant trials.
- To determine if clinical signs or biological markers can reliably predict antidepressant efficacy.
Summary:
- Retardation emerged as a potential predictor of positive antidepressant response.
- The predictive value of other endogenous signs (insomnia, weight loss) is uncertain.
- Biochemical parameters, neuroendocrine indices (DST), and physiological sleep EEG characteristics (REM latency) show limited or inconsistent predictive power.
- Pharmacological challenges yielded unreliable results and raise ethical concerns.
Impact:
- Currently, no routine, reliable biological index exists to predict antidepressant response.
- Further research is needed to identify robust biomarkers for guiding antidepressant selection.
- Advances in this area could lead to more effective and personalized depression treatments.